HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

NCT04135690 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: Hepatic arterial infusion chemotherapy
DRUG: Toripalimab
DRUG: Sorafenib
DRUG: systemic treatment

Sponsor

Sun Yat-sen University